Resultats de la cerca - Xianggui Yuan
- Mostrar 1 - 4 resultats de 4
-
1
-
2
-
3
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial per Wen Lei, Hui Liu, Wenhai Deng, Wei Chen, Yun Liang, Wenxia Gao, Xianggui Yuan, Shanshan Guo, Ping Li, Jinyong Wang, Xiangmin Tong, Yi Eve Sun, Aibin Liang, Wenbin Qian
Publicat 2025Artigo -
4
Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial per Wen Lei, Hui Liu, Wenhai Deng, Wei Chen, Yun Liang, Wenxia Gao, Xianggui Yuan, Shanshan Guo, Ping Li, Jinyong Wang, Xiangmin Tong, Yi Eve Sun, Aibin Liang, Wenbin Qian
Publicat 2025Errata/Corrigenda
Eines de cerca:
Matèries relacionades
Medicine
Cancer research
Internal medicine
Oncology
CD19
Immunology
Biology
Bone marrow
Chimeric antigen receptor
Composite material
Cytokine release syndrome
Disease
Etiology
Gene
Genetics
Immune system
Intramedullary rod
Leukemia
Lymphoma
Materials science
Modalities
Myeloid
Myeloid leukemia
Osteolysis
Pediatrics
Peripheral blood
Presentation (obstetrics)
Radiation therapy
Refractory (planetary science)
Social science